Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
68,779,684
-
Share change
-
+4,620,011
-
Total reported value
-
$2,044,301,959
-
Put/Call ratio
-
5.7%
-
Price per share
-
$29.72
-
Number of holders
-
247
-
Value change
-
+$133,468,390
-
Number of buys
-
135
-
Number of sells
-
101
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2017
As of 30 Sep 2017,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,779,684 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, Bank of New York Mellon Corp, Standard Life Aberdeen plc, DIMENSIONAL FUND ADVISORS LP, Van Berkom & Associates Inc., and GW&K Investment Management, LLC.
This page lists
247
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.